NONALCOHOLIC FATTY LIVER DISEASE
Clinical trials for NONALCOHOLIC FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new NONALCOHOLIC FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for NONALCOHOLIC FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for NASH: drug targets liver scarring in advanced disease
Disease control OngoingThis study tests an experimental drug, GSK4532990, in 284 adults with NASH (a type of fatty liver disease) and significant liver scarring. The goal is to see if the drug can reduce scarring and inflammation without making the disease worse. Participants receive either the drug or…
Matched conditions: NONALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 01, 2026 20:12 UTC
-
Stomach stitching without surgery: can it reverse fatty liver?
Disease control OngoingThis study tests a non-surgical stomach-reduction procedure called endoscopic sleeve gastroplasty (ESG) in 30 obese adults with nonalcoholic fatty liver disease (NAFLD). The goal is to see if weight loss from ESG improves liver fat and stiffness, along with overall health and qua…
Matched conditions: NONALCOHOLIC FATTY LIVER DISEASE
Sponsor: West Virginia University • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Fatty liver secrets revealed: scientists hunt for clues in biopsies
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to identify which types of fats and proteins are linked to more severe nonalcoholic fatty liver disease (NAFLD). Researchers will analyze liver tissue samples from 45 adults undergoing abdominal or bariatric surgery. No treatment is given; the goal is simply to le…
Matched conditions: NONALCOHOLIC FATTY LIVER DISEASE
Sponsor: Vanderbilt University • Aim: Knowledge-focused
Last updated Apr 28, 2026 13:02 UTC